6702:TSEFujitsu Limited Analysis
Data as of 2026-03-10 - not real-time
¥3,657.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Fujitsu’s shares are trading below both the short‑term and medium‑term moving averages, with momentum indicators hovering around neutral territory and a bullish MACD histogram suggesting a short‑term upside bias. Volume has been picking up, and the price sits comfortably above a key support level while still leaving room to climb toward the next resistance zone.
Fundamentally, the company trades at a price‑earnings multiple well under the industry average, yet a discounted cash‑flow model places fair value below the current market price, indicating a modest overvaluation on a pure valuation basis. The firm’s cash generation is strong, dividend payout is modest and well‑covered, and a new collaboration on digital health, together with an AI partnership with NVIDIA, adds a strategic growth catalyst despite a recent dip in revenue growth. Overall, the blend of a solid balance sheet, sustainable dividend, and emerging AI initiatives supports a cautiously optimistic outlook, while elevated volatility and sector dynamics temper the upside.
Fundamentally, the company trades at a price‑earnings multiple well under the industry average, yet a discounted cash‑flow model places fair value below the current market price, indicating a modest overvaluation on a pure valuation basis. The firm’s cash generation is strong, dividend payout is modest and well‑covered, and a new collaboration on digital health, together with an AI partnership with NVIDIA, adds a strategic growth catalyst despite a recent dip in revenue growth. Overall, the blend of a solid balance sheet, sustainable dividend, and emerging AI initiatives supports a cautiously optimistic outlook, while elevated volatility and sector dynamics temper the upside.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram indicating momentum shift
- Increasing trading volume supporting price stability
- Proximity to support with upside potential toward resistance
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Revenue contraction offset by strong cash flow and dividend yield
- Strategic AI and digital health collaborations expanding future addressable market
- Valuation near fair value with limited upside from current pricing
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend supported by robust free cash flow
- Long‑term growth prospects from AI infrastructure partnership with NVIDIA
- Solid return on equity and stable balance sheet despite market volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-4.30%
Profit Margin13.23%
P/E Ratio22.5
ROE16.86%
ROA6.93%
Debt/Equity6.68
P/B Ratio3.2
Op. Cash Flow¥395.7B
Free Cash Flow¥324.1B
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI45.7
Support¥3,284.00
Resistance¥4,170.00
MA 20¥3,660.00
MA 50¥4,044.24
MA 200¥3,747.62
MACDBullish
VolumeIncreasing
Fear & Greed Index79.32
Valuation
Fair Value¥2,747.28
Target Price¥4,946.15
Upside/Downside35.25%
GradeFair
TypeBlend
Dividend Yield1.36%
Risk Assessment
Beta0.62
Volatility57.74%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.